5K0U image
Entry Detail
PDB ID:
5K0U
EMDB ID:
Keywords:
Title:
CryoEM structure of the full virion of a human rhinovirus C
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2016-05-17
Release Date:
2016-07-13
Method Details:
Experimental Method:
Resolution:
2.79 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Capsid protein VP1
Mutations:T125K
Chain IDs:A
Chain Length:279
Number of Molecules:1
Biological Source:Rhinovirus C
Polymer Type:polypeptide(L)
Description:Capsid protein VP3
Chain IDs:B
Chain Length:235
Number of Molecules:1
Biological Source:Rhinovirus C
Polymer Type:polypeptide(L)
Description:Capsid protein VP2
Chain IDs:C
Chain Length:265
Number of Molecules:1
Biological Source:Rhinovirus C
Polymer Type:polypeptide(L)
Description:Capsid protein VP4
Chain IDs:D
Chain Length:66
Number of Molecules:1
Biological Source:Rhinovirus C
Primary Citation
Atomic structure of a rhinovirus C, a virus species linked to severe childhood asthma.
Proc.Natl.Acad.Sci.USA 113 8997 9002 (2016)
PMID: 27511920 DOI: 10.1073/pnas.1606595113

Abstact

Isolates of rhinovirus C (RV-C), a recently identified Enterovirus (EV) species, are the causative agents of severe respiratory infections among children and are linked to childhood asthma exacerbations. The RV-C have been refractory to structure determination because they are difficult to propagate in vitro. Here, we report the cryo-EM atomic structures of the full virion and native empty particle (NEP) of RV-C15a. The virus has 60 "fingers" on the virus outer surface that probably function as dominant immunogens. Because the NEPs also display these fingers, they may have utility as vaccine candidates. A sequence-conserved surface depression adjacent to each finger forms a likely binding site for the sialic acid on its receptor. The RV-C, unlike other EVs, are resistant to capsid-binding antiviral compounds because the hydrophobic pocket in VP1 is filled with multiple bulky residues. These results define potential molecular determinants for designing antiviral therapeutics and vaccines.

Legend

Protein

Chemical

Disease

Primary Citation of related structures